Edition:
United States

Biotest AG (BIOG_p.DE)

BIOG_p.DE on Xetra

20.00EUR
13 Dec 2017
Change (% chg)

-- (--)
Prev Close
€20.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
28,715
52-wk High
€23.88
52-wk Low
€12.96

Chart for

About

Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology and intensive care medicine. Biotest AG develops, manufactur... (more)
No analyst recommendations are available for .

Overall

Beta: 0.62
Market Cap(Mil.): €999.67
Shares Outstanding(Mil.): 39.57
Dividend: 0.05
Yield (%): 0.18

Financials

  Industry Sector
P/E (TTM): -- 31.14 16.44
EPS (TTM): -- -- --
ROI: -- 14.86 10.62
ROE: -- 16.28 14.20

BRIEF-Biotest 9-mth revenue at EUR 377.8 mln

* DGAP-NEWS: BIOTEST AG: BIOTEST GENERATES REVENUES OF EUR 377.8 MILLION IN THE FIRST NINE MONTHS 2017

Nov 14 2017

UPDATE 1-Takeover of plasma firm Biotest by China's Creat hits wall in U.S.

* Biotest shares drop 12 percent to 7-month low (Adds share price, background)

Nov 07 2017

China's Creat suffers setback in Biotest deal on U.S. scrutiny

FRANKFURT Chinese investor Creat Group Corp has withdrawn its application for U.S. approval of a planned 1.3-billion-euro ($1.51-billion) takeover of Biotest , the German blood plasma products maker said, sending its shares sharply lower.

Nov 07 2017

BRIEF-Biotest: Tiancheng withdrawal of application of transaction from CFIUS and refiling

* ‍TENDER OFFER BY TIANCHENG (GERMANY) PHARMACEUTICAL HOLDINGS AG​

Nov 07 2017

BRIEF-Curetis partners with Biotest to support academic PEPPER Pentaglobin Peritonitis trial

* CURETIS PARTNERS WITH BIOTEST TO SUPPORT ACADEMIC PEPPER PENTAGLOBIN® PERITONITIS TRIAL WITH UNYVERO IAI APPLICATION

Aug 15 2017

BRIEF-Biotest H1 result swings to loss of 17.8 million euros

* H1 REVENUE FROM CONTINUING OPERATIONS FELL 11 PERCENT TO 247.1 MILLION EUR

Aug 14 2017

BRIEF-Biotest takes over plasma supplier Cara Plasma s.r.o.

* ‍BIOTEST TAKES OVER CARA PLASMA S.R.O. WITH ONE PLASMA COLLECTION CENTRE IN CZECH REPUBLIC​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Jul 19 2017

BRIEF-Tiancheng Pharmaceutical Holdings: offer for Biotest accepted for 89.9 pct of share capital‍​‍​

* TIANCHENG (GERMANY) PHARMACEUTICAL HOLDINGS AG - AFTER END OF ADDITIONAL ACCEPTANCE PERIOD OFFER ACCEPTED FOR 17.8 MILLION BIOTEST SHARES, THAT IS 89.9% SHARE CAPITAL‍​‍​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Jul 07 2017

BRIEF-Biotest reaches 2nd milestone in expansion project

* DGAP-NEWS: BIOTEST AG: BIOTEST REACHES 2ND MILESTONE IN BIOTEST NEXT LEVEL EXPANSION PROJECT

Jun 22 2017

BRIEF-Tiancheng Pharmaceutical Holdings: additional acceptance period for Biotest tender offer

* START OF MANDATORY ADDITIONAL ACCEPTANCE PERIOD FOR BIOTEST AG TENDER OFFER Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Jun 21 2017

Earnings vs. Estimates